Anyone have any idea how the old Arrow Vascular Access business is doing inside Teleflex these days ?
We are a steady 2% growth company. Our new model is to copy everything Bard is doing and become a strong #2.
WOW! Say what you want, but the Vascular Access business unit has really hit the map! Forget being #2, we won't settle for anything but market dominance. Recent acquisitions are giving us a broad and substantial offering to clients. Stock didn't jump yet, but it will...very soon and I predict a continuous rise as investors can't deny the revenue growth driven by our astute leadership team. What say you?